Concepedia

Author

Dawei Wu

Qilu Hospital of Shandong UniversityORCID

Also Known As

C. Xie, D W Wu, D Wu, D. Wu, Da-Wei Wu, Da-wei WU, Da-wei Wu, DaWei Wu, Daqun Wu, Dawei Wu

197

Publications

4.3K

Citations

33

H-Index

106

Concepts

All Affiliations

Qilu Hospital of Shandong UniversityChinese Academy of Medical Sciences & Peking Union Medical CollegeShandong UniversityWuhan UniversityTianjin Medical University General Hospital
DW

About

Dawei Wu is an author at Qilu Hospital of Shandong University specializing in medicine, cell biology, and inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

25

879

2

Health Sciences

3

3

123

3

Public Health

3

3

90

4

Biochemistry

2

2

35

5

Allergy

1

1

13

Dawei Wu

×

64

Publications

3.4K

Citations

30

H-Index

YearCitations

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC

Shugeng Gao, Ning Li, Shun‐Yu Gao,

Journal of Thoracic Oncology

2020

399

Epidemiology and Outcome of Severe Sepsis and Septic Shock in Intensive Care Units in Mainland China

Jianfang Zhou, Chuanyun Qian, Mingyan Zhao,

PLoS ONE

2014

226

Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma

Jing Huang, Binghe Xu, Hongnan Mo,

Clinical Cancer Research

2018

216

Predictive Value of Serum Albumin Level for the Prognosis of Severe Sepsis Without Exogenous Human Albumin Administration: A Prospective Cohort Study

Mei Yin, Lei Si, Weidong Qin,

Journal of Intensive Care Medicine

2016

189

XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial

Yuanlin Song, Chen Yao, Yongming Yao,

Critical Care Medicine

2019

159

Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma

Xiaodong Jia, Shanshan Lu, Zhen Zeng,

Hepatology

2019

158

Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study

Hongnan Mo, Jing Huang, Jiachen Xu,

British Journal of Cancer

2018

156

Disruption of USP9X in macrophages promotes foam cell formation and atherosclerosis

Biqing Wang, Xuening Tang, Yao Liu,

Journal of Clinical Investigation

2022

113

Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial

Bo Zhang, Jing Huang, Jialin Tang,

Journal for ImmunoTherapy of Cancer

2021

101

Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis

Songqiao Liu, Chen Yao, Jianfeng Xie,

JAMA Internal Medicine

2023

92

Page 1